Literature DB >> 11289389

Spontaneous acute tumor lysis syndrome with advanced gastric cancer.

I S Woo1, J S Kim, M J Park, M S Lee, R W Cheon, H M Chang, J S Ahn, J A Lee, Y I Park, Y S Park, J W Shim, I Yang.   

Abstract

Acute tumor lysis syndrome (TLS) occurs frequently in hematologic malignancies such as high-grade lymphomas and acute leukemia, which are rapidly proliferating and chemosensitive tumors. It occurs rarely in solid tumors and has never been reported in gastric adenocarcinoma. Typical biochemical findings of acute tumor lysis syndrome are hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia in patients with a malignancy. Rapid changes of these electrolytes may cause cardiac arrhythmia, seizure, acute renal failure and sudden death. Therefore, as soon as it is detected, it should be taken care of immediately. Until now almost all cases of TLS associated with solid tumor have developed after cytoreductive therapy in chemosensitive tumors. We report here a case of spontaneous acute tumor lysis in a patient of advanced gastric cancer with hepatic metastases and multiple lymphadenopathy. The biochemical finding of TLS improved with the management and tumor burden also showed slight response to the one cycled combination chemotherapy but the patient died of progressive pneumonia.

Entities:  

Mesh:

Year:  2001        PMID: 11289389      PMCID: PMC3054572          DOI: 10.3346/jkms.2001.16.1.115

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  20 in total

Review 1.  Spontaneous tumour lysis syndrome.

Authors:  Natasha Kekre; Bojana Djordjevic; Claire Touchie
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

2.  Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma.

Authors:  Mevlut Kurt; Ibrahim K Onal; Tamer Elkiran; Bulent Altun; Kadri Altundag; Ibrahim Gullu
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 3.  Spontaneous acute tumour lysis syndrome in gastric adenocarcinoma: a case report and literature review.

Authors:  Hemant Goyal; Harinder Sawhney; Swetha Bekara; Umesh Singla
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Authors:  Zhong Ye; Juan P Palazzo; Liz Lin; Yinzhi Lai; Fran Guiles; Ronald E Myers; Jin Han; Jinliang Xing; Hushan Yang
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

5.  Maxillary Sinus Squamous Cell Carcinoma Presenting with Fatal Tumor Lysis Syndrome: A Case Report and Review of the Literature.

Authors:  Mirna Abboud; Ali Shamseddine
Journal:  Case Rep Oncol       Date:  2009-11-25

6.  Acute tumor lysis syndrome in a hemodialysis patient with diffuse large B cell lymphoma.

Authors:  Cheng-Jui Lin; Han-Hsiang Chen; Ruey-Kuen Hsieh; Yi-Chou Chen; Chih-Jen Wu
Journal:  Med Oncol       Date:  2008-09-03       Impact factor: 3.064

Review 7.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

8.  Hyperuricemic renal failure in nonhematologic solid tumors: a case report and review of the literature.

Authors:  Neeraj Saini; Kyeong Pyo Lee; Smita Jha; Sanket Patel; Neelima Bonthu; Ankit Kansagra; Ashmeet Bhatia; Sandra E Martinez; Jaymin Patel; Sarah Altamimi; Sara Ghotb
Journal:  Case Rep Med       Date:  2012-05-27

9.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

10.  Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma.

Authors:  Robin Moiseff; Cameron Felty; Xiaoying Liu
Journal:  Autops Case Rep       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.